Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US74834L1008
Ticker DGX
Company QUEST DIAGNOSTICS
Currency $
Price
Aware Investor Index (AII) 0.8158
Recommendation BUY
P/E 18.60
ROE 13.30 %
Capitalization 12,258,400,000 $
Dividend Yield 2.06 %
P/S 1.59
AII Position 270
P/E Position 245
ROE Position 261
Capitalization Position 431
Dividend Yield Position 369
Sales 7,709,000,000 $
10-Year Average Earnings 658,878,300 $
Shares Outstanding 140,000,000
Equity 4,955,000,000 $
Dividend per Share 1.8 $
Industry Healthcare
Country United States
QUEST DIAGNOSTICS Investor Relations Web Site http://ir.questdiagnostics.com/







Sales:

YEAR MONTH AMOUNT
2017 12 7,709,000,000.00 $
2016 12 7,515,000,000.00 $
2015 12 7,493,000,000.00 $
2014 12 7,435,000,000.00 $
2013 12 7,146,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 772,000,000.00 $
2016 12 645,000,000.00 $
2015 12 709,000,000.00 $
2014 12 556,000,000.00 $
2013 12 849,000,000.00 $
2012 12 555,721,000.00 $
2011 12 470,567,000.00 $
2010 12 720,894,000.00 $
2009 12 729,111,000.00 $
2008 12 581,490,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 4,955,000,000.00 $
2016 12 4,660,000,000.00 $
2015 12 4,713,000,000.00 $
2014 12 4,330,000,000.00 $
2013 12 3,973,000,000.00 $
2012 12 4,185,729,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 140,000,000
2016 12 142,000,000
2015 12 145,000,000
2014 12 145,000,000
2013 12 153,000,000
2012 12 160,065,000

 












Bloomberg News for QUEST DIAGNOSTICS:



Google News for QUEST DIAGNOSTICS:

StreetInsider.com - 27 Nov 2018
Quest Diagnostics (DGX) to Acquire the Laboratory Services ...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive ...
Nasdaq
Credit Suisse Group Cuts Quest Diagnostics (NYSE:DGX) Price ...
Quest Diagnostics (NYSE:DGX) had its target price reduced by stock analysts at Credit Suisse Group from $121.00 to $103.00 in a report ...
Fairfield Current - 5 hours ago
Quest Diagnostics (DGX) Has Fallen To A New Low After Guidance ...
(RTTNews.com) - Quest Diagnostics ( DGX ) announced after the bell Wednesday that it now expects to report full year adjusted EPS of greater ...
The FinExaminer
Quest Diagnostics (DGX) Up 1.9% Since Last Earnings Report: Can ...
A month has gone by since the last earnings report for Quest Diagnostics (DGX). Shares have added about 1.9% in that time frame, ...
PressOracle
Quest guidance cut a surprise - KeyBanc
KeyBanc's Donald Hooker says Quest Diagnostics' (NYSE:DGX) softer 2018 outlook and modest growth expectations (4 - 6%) surprised ...
Baseball Daily News
Barclays Lowers Quest Diagnostics (DGX) Price Target to $117.00
Quest Diagnostics (NYSE:DGX) had its target price reduced by Barclays from $125.00 to $117.00 in a research note issued to investors on ...
Nasdaq - 29 Nov 2018
Current Fundamentals: Quest Diagnostics (NYSE: DGX)
Quest Diagnostics is part of the healthcare sector and trades as part of the medical diagnostics and research industry. The company CEO is ...
Motley Fool
Quest Diagnostics to acquire Midwest reference lab
Quest Diagnostics (NYSE:DGX) has agreed to acquire Columbia, MO-based Boyce and Bynum Pathology Laboratories for an undisclosed sum ...
Seeking Alpha
Mizuho Securities Remains Bullish on Quest Diagnostics (DGX)
Mizuho Securities analyst, Ann Hynes, reiterated a Buy rating and $108.00 price target on Quest Diagnostics (NYSE: DGX) ahead of the ...
FDA Headlines
Quest Diagnostics Incorporated (NYSE:DGX): Studying the Analyst ...
Sell-side analysts following Quest Diagnostics Incorporated (NYSE:DGX) have been making their best calculations on where they believe the ...


Back